TABLE 5.
Serious TEAE, n (%) |
Moderate‐frequency usage (<2 doses/month) (n = 69) |
High‐frequency usage (2‐5 doses/month) (n = 80) |
Very‐high‐frequency usage (>5 doses/month) (n = 9) |
---|---|---|---|
Seizure | 10 (14.5) | 7 (8.8) | 1 (11.1) |
Seizure cluster | 2 (2.9) | — | — |
Status epilepticus | — | 5 (6.3) | — |
Pneumonia | 4 (5.8) | 3 (3.8) | — |
Pyrexia | — | 2 (2.5) | — |
Abbreviation: TEAE, treatment‐emergent adverse event.